Retraction Note: Selinexor (KPT-330) has antitumor activity against anaplastic thyroid carcinoma in vitro and in vivo and enhances sensitivity to doxorubicin
Open Access
- 15 December 2025
- journal article
- retraction
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 43808
Abstract
No abstract availableKeywords
This publication has 1 reference indexed in Scilit: